SurvivorNet on MSN
Targeted drug Epkinly is suddenly front & center in lymphoma care: Here’s what patients need to know
The FDA approved Epkinly in combination with other standard lymphoma drugs, rituximab + lenalidomide, for relapsed or ...
Cervical lymphadenopathy presents a shared anatomic challenge for clinicians, yet it serves as the divergent starting point ...
Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...
How Does Epkinly Work to Treat Lymphoma? Epkinly is a special type of molecule that can attach to two different types of cells. This is called a bispecific antibody. It attaches to CD20 proteins on ...
Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.
PetGuide.com on MSN
FDA Approves Oral Medication for Treating Lymphoma in Dogs
On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval ...
Brescia Dover had just returned from studying abroad in Italy when she was diagnosed with lymphoma at 20 She found comfort and heroism in her hematologist, Dr. Allison Rosenthal, who was diagnosed ...
20hon MSNOpinion
People live longer with cancer. That's good news, but | Opinion
Better treatment and earlier diagnosis mean that 7 in 10 people will survive five years or more after a cancer diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results